{"id":"sevoflurane-neostigmine-70","safety":{"commonSideEffects":[{"rate":null,"effect":"Postoperative nausea and vomiting"},{"rate":null,"effect":"Emergence agitation"},{"rate":null,"effect":"Hepatotoxicity (rare)"},{"rate":null,"effect":"Malignant hyperthermia (rare)"},{"rate":null,"effect":"Cholinergic effects from neostigmine (salivation, bronchospasm)"}]},"_chembl":{"chemblId":"CHEMBL278020","moleculeType":"Small molecule","molecularWeight":"223.30"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sevoflurane is a volatile anesthetic agent that depresses the central nervous system to produce unconsciousness and analgesia during surgery. Neostigmine is an acetylcholinesterase inhibitor that prevents the breakdown of acetylcholine, thereby enhancing neuromuscular transmission and reversing the effects of non-depolarizing neuromuscular blocking agents used during anesthesia.","oneSentence":"This is a combination of sevoflurane (a volatile anesthetic) and neostigmine (a cholinesterase inhibitor) used to maintain anesthesia and reverse neuromuscular blockade.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:37:34.836Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"General anesthesia maintenance during surgical procedures"},{"name":"Reversal of neuromuscular blockade post-operatively"}]},"trialDetails":[{"nctId":"NCT05253404","phase":"NA","title":"Laryngeal Mask Airway Facilitates a Safe and Smooth Emergence From Anesthesia in Patients Undergoing Craniotomy","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2022-02-15","conditions":"Complications, Pulmonary","enrollment":62},{"nctId":"NCT04562181","phase":"NA","title":"Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index","status":"COMPLETED","sponsor":"China Medical University, China","startDate":"2020-09-30","conditions":"Anesthesia Monitor, Electroencephalography, Sleep","enrollment":30},{"nctId":"NCT05037006","phase":"PHASE4","title":"Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade","status":"UNKNOWN","sponsor":"Pontificia Universidade Catolica de Sao Paulo","startDate":"2021-10-01","conditions":"Neuromuscular Blockade, Neuromuscular Blockade, Residual","enrollment":90},{"nctId":"NCT01199237","phase":"PHASE4","title":"Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-08","conditions":"Airway Reflexes, Protective, Recovery After Neuromuscular Block, Anesthetic Recovery","enrollment":107}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Inhalational anesthesia"],"phase":"marketed","status":"active","brandName":"Sevoflurane - Neostigmine 70","genericName":"Sevoflurane - Neostigmine 70","companyName":"Pontificia Universidade Catolica de Sao Paulo","companyId":"pontificia-universidade-catolica-de-sao-paulo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a combination of sevoflurane (a volatile anesthetic) and neostigmine (a cholinesterase inhibitor) used to maintain anesthesia and reverse neuromuscular blockade. Used for General anesthesia maintenance during surgical procedures, Reversal of neuromuscular blockade post-operatively.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}